CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Trial to Evaluate the Safety and Tolerability of Nebulised Amphotericin B Lipid Complex (ABELCET®) in the Prophylaxis of Invasive Pulmonary Aspergillosis During Prolonged Neutropenia in Paediatric Patients With Acute Leukaemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01615809
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:58.376996+00:00
Published At: 2015-10-23T00:00:00+00:00
Record Updated At: 2018-03-29
Results Posted At: 2015-10-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Invasive Pulmonary Aspergillosis", "Lymphoblastic Leukaemia", "Myeloblastic Leukaemia", "Lymphoblastic Leukemia", "Myeloblastic Leukemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-03-29"
protocolSection.identificationModule.nctId: "NCT01615809"
protocolSection.identificationModule.officialTitle: "A Phase II Trial to Evaluate the Safety and Tolerability of Nebulised Amphotericin B Lipid Complex (ABELCET\u00ae) in the Prophylaxis of Invasive Pulmonary Aspergillosis During Prolonged Neutropenia in Paediatric Patients With Acute Leukaemia"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2015-10-23"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.